Instil Bio
TIL
NASDAQ
IPO2021
about TIL
Instil Bio is a biotechnology company specializing in the development of innovative therapies through cell and gene engineering, focusing on advancing treatments for complex conditions such as cancer and rare genetic disorders.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.69 | $7.38 | $6.68 | $45.17M | 855.54K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$2.01 | n/a | n/a | 0% | 0% | 0% |